Conbercept for patients with age-related macular degeneration: a systematic review

Conbercept for patients with age-related macular degeneration: a systematic review

Abstract Background Conbercept is a novel vascular endothelial growth factor (VEGF) inhibitor for the treatment of wet age-related macular degeneration (AMD). This systematic review aims to assess the efficacy and safety of conbercept in the treatment of wet AMD. Methods PubMed, Embase, Cochrane Lib...

Full description

Bibliographic Details
Main Authors: Jiaxing Zhang, Yi Liang, Juan Xie, Dong Li, Qian Hu, Xiaosi Li, Wenyi Zheng, Rui He
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Ophthalmology
Subjects:
Wet age-related macular degeneration
Vascular endothelial growth factor (VEGF) inhibitor
Conbercept
Ranibizumab
Systematic review
Online Access:http://link.springer.com/article/10.1186/s12886-018-0807-1

Internet

http://link.springer.com/article/10.1186/s12886-018-0807-1

Similar Items